全体要約
デバイスタイプ別では、診断薬受託製造市場は、体外診断機器、診断画像機器、その他の機器に区分されます。診断画像機器は、CT、X線、MRI、超音波などを含みます。また、地域別ではアジア太平洋地域が最も高い成長率を示し、特に低賃金と急速な医療インフラの変化が大きな潜在能力を秘めています。主要企業には、Jabil Inc.、Flex Ltd.、Plexus Corp.などが含まれます。
関連する質問
44.9ビリオンUSD（2028年）
11.5%（2023年から2028年）
Jabil Inc. (US), Flex Ltd. (Singapore), Plexus Corp. (US), Sanmina Corporation (US), TE Connectivity Ltd. (Switzerland), Celestica Inc. (Canada), Integer Holdings Corporation (US), Nipro Corporation (Japan), Thermo Fisher Scientific (US), West Pharmaceutical Services Inc. (US), Benchmark Electronics Inc. (US), Kimball Electronics Inc. (US), KMS Systems (US), Savyon Diagnostics (Israel), Nova Biomedical (US), Cenogenics Corporation (US), Cone Bioproducts (US), Avioq, Inc. (US), Philips-Medisize Corporation (US), Invetech (Australia), Meridian Bioscience, Inc. (US), Nolato AB (Sweden), Fujirebio (Japan), Sekisui (US), Prestige Diagnostics (UK), Biokit (Spain)
製造プロセスにおけるロボットと自動化の採用の増加、臨床応用の範囲の拡大、IVD製造業者によるアウトソーシング活動の増加
概要
「診断契約製造市場において、デバイス別で診断画像機器セグメントが予測期間中に最も高い成長率を占めました。」
種類別に基づいて、診断契約製造市場は、体外診断装置、診断画像装置、その他の装置に区分されています。診断画像装置には、CT、X線、MRI、超音波、その他の画像装置が含まれています。急速な経済成長により、これらの装置の導入は今後数年で発展途上国で増加することが予想されています。
整形外科のアプリケーションセグメントは、診断画像機器のアプリケーションの中で予測期間中に最も高いCAGRを占めました。
用途に基づいて、診断画像装置市場は心臓病学、神経学、整形外科、腫瘍学、その他に分類されます。2022年には、心臓病学が市場を支配し、整形外科が最も高い成長率を記録しました。整形外科分野の成長を支える要因は、高齢者人口の増加と整形外科疾患や障害の蔓延です。
「アジア太平洋地域は、予測期間中に診断契約製造システム市場で最高の成長率を占めました。」
地域に基づいて、グローバルな診断受託製造市場は北米、ヨーロッパ、アジア太平洋、その他の地域に分類されます。アジア太平洋は、予測期間中に高い成長率を示すと予想されています。低い労働コストと急速に変化するヘルスケアインフラは、アジア太平洋の診断受託製造市場に大きな潜在能力を持っています。
企業タイプ、役職、地域別の供給側主要インタビューの内訳：
・会社の種類別：Tier 1 - 55%、Tier 2 - 40%、Tier 3 - 5%
• 職位別: Cレベル - 37%、ディレクターレベル - 48%、その他 - 15%
地域別：北米 - 56%、ヨーロッパ - 17%、アジア太平洋 - 20%、その他の地域 - 7%
著名な企業には、Jabil Inc.（米国）、Flex Ltd.（シンガポール）、Plexus Corp.（米国）、Sanmina Corporation（米国）、TE Connectivity Ltd.（スイス）、Celestica Inc.（カナダ）、Integer Holdings Corporation（米国）、Nipro Corporation（日本）、Thermo Fisher Scientific（米国）、West Pharmaceutical Services Inc.（米国）、Benchmark Electronics Inc.（米国）、Kimball Electronics Inc.（米国）、KMS Systems（米国）、Savyon Diagnostics（イスラエル）、Nova Biomedical（米国）、Cenogenics Corporation（米国）、Cone Bioproducts（米国）、Avioq, Inc.（米国）、Philips-Medisize Corporation（米国）、Invetech（オーストラリア）、Meridian Bioscience, Inc.（米国）、Nolato AB（スウェーデン）、Fujirebio（日本）、Sekisui（米国）、Prestige Diagnostics（英国）、およびBiokit（スペイン）などがあります。
調査範囲
この調査報告書は、診断契約製造市場をデバイス（体外診断機器、診断画像機器、その他の機器）、サービス（デバイス開発および製造サービス、品質管理サービス、パッケージおよび組み立てサービス、その他のサービス）、最終ユーザー（体外診断機器（感染症、腫瘍学、心臓病学、その他）、診断画像機器（心臓病学、腫瘍学、整形外科、神経学、その他）、その他の機器（消化器学、婦人科、その他）、および地域（北アメリカ、ヨーロッパ、アジア太平洋、その他の地域）によって分類しています。この報告書の範囲は、診断契約製造市場の成長に影響を与える主要要因（ドライバー、制約、課題、機会）に関する詳細情報をカバーしています。主要な業界プレイヤーの詳細分析が行われ、彼らのビジネス概要、ソリューション、サービス、主要戦略、契約、パートナーシップ、および合意についての洞察が提供されています。新製品およびサービスの投入、合併と買収、診断契約製造市場に関連する最近の開発についても扱っています。この報告書では、診断契約製造市場エコシステムにおける新興スタートアップの競争分析もカバーされています。
レポート購入の主な利点：
この報告書は、全体の診断契約製造市場およびサブセグメントにおける収益数値の最も近い近似に関する情報を市場のリーダーや新規参入者に提供します。この報告書は、利害関係者が競争環境を理解し、ビジネスを適切に位置付け、適切な市場投入戦略を計画するための洞察を得るのに役立ちます。また、この報告書は利害関係者が市場の動向を理解し、主要な市場ドライバー、制約、課題、および機会に関する情報を提供します。
レポートは以下のポイントに関する洞察を提供します。
• 主要な推進要因の分析（早期診断と臨床応用の範囲拡大、製造プロセスにおけるロボットおよび自動化の採用、IVDメーカーによるアウトソーシング活動の増加、社内IVD製造の高コスト）、制約（知的財産保護の懸念と盗難の可能性）、機会（新興経済国における成長の機会）、および課題（リファービッシュされた診断イメージングシステムの採用の増加、技術的能力とコストのバランスを取るための継続的な革新の欠如、熟練労働者の不足）。
• 市場開発: 有望な市場に関する包括的な情報 - このレポートは、さまざまな地域における診断受託製造市場を分析しています。
市場の多様化：診断契約製造市場における新製品やサービス、未開拓の地域、最近の発展、投資に関する詳細な情報です。
• 競争評価：診断契約製造市場戦略における主要プレーヤーであるジェイビル社（米国）、フレックス社（シンガポール）、プレクサス社（米国）、サンミナ社（米国）、TEコネクティビティ社（スイス）、セレスティカ社（カナダ）などの市場シェア、成長戦略、サービス提供の詳細な評価です。
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 イントロダクション 30
1.1 調査の目的 30
1.2 市場の定義 30
1.3 調査範囲 32
1.3.1 対象年 33
1.4 通貨 33
1.5 ステークホルダー 33
2 調査手法 34
2.1 リサーチデータ 34
2.1.1 二次データ 35
- 2.1.1.1 二次情報の主要データ 36
2.1.2 一次データ 37
2.1.3 業界についての主な考察 38
- 2.1.3.1 一次情報の主要データ 38
- 2.1.3.2 一次インタビュー内訳 39
2.2 市場規模予測 39
2.2.1 ボトムアップアプローチ 39
- 2.2.1.1 アプローチ1：会社の収益推定アプローチ 40
- 2.2.1.2 アプローチ2：企業プレゼンテーションと一次インタビュー 40
- 2.2.1.3 アプローチ3：COGSアプローチ 40
- 2.2.1.4 アプローチ4：親市場アプローチ（社内市場対アウトソーシング市場） 41
- 2.2.1.5 成長予測 42
- 2.2.1.6 CAGR予測 42
2.2.2 トップダウンアプローチ 42
2.3 データのトライアンギュレーション 44
2.4 調査の前提 45
2.5 研究の限界とリスク評価 45
3 エグゼクティブサマリー 47
4 更なる考察 50
4.1 診断薬受託製造市場の概要 50
4.2 診断薬受託製造市場、地域別（2023年～2028年） 51
4.3 アジア太平洋地域の診断薬受託製造市場：デバイスタイプ別、国別（2022年） 52
4.4 診断薬受託製造市場、地理的側面での成長機会 53
5 市場概要 54
5.1 イントロダクション 54
5.2 市場ダイナミクス 54
5.2.1 促進要因 55
5.2.2 抑制要因 57
- 5.2.2.1 知的財産保護の懸念と知的財産盗難の可能性 57
5.2.3 市場機会 57
- 5.2.3.1 新興国における成長機会 57
5.2.4 課題 57
- 5.2.4.1 画像診断装置のリファービッシュタイプの採用が進む 57
- 5.2.4.2 技術力とコストのバランスを取るための絶え間ない技術革新の欠如 58
- 5.2.4.3 スキル人材不足 58
5.3 サプライチェーン分析 58
5.4 ポーターのファイブフォース分析 59
5.4.1 新規参入の脅威 59
5.4.2 代替品の脅威 60
5.4.3 サプライヤーの交渉力 60
5.4.4 買い手の交渉力 60
5.4.5 競合・競争状況の激しさ 61
5.5 エコシステム分析 61
5.5.1 エコシステムにおける役割 62
5.6 規制分析 63
5.6.1 北米 64
- 5.6.1.1 米国 64
- 5.6.1.2 カナダ 64
5.6.2 ヨーロッパ 65
5.6.3 アジア太平洋 65
- 5.6.3.1 日本 65
- 5.6.3.2 中国 66
- 5.6.3.3 インド 68
5.7 2022-2023年の主な会議・イベント 68
5.8 技術分析 70
6 診断薬受託製造の市場、デバイスタイプ別 71
6.1 イントロダクション 72
6.2 体外診断薬デバイス 72
6.2.1 IVD消耗品 73
- 6.2.1.1 消耗品部門がIVD受託製造市場を支配 73
6.2.2 IVD装置 74
- 6.2.2.1 自動化、進歩、効率的な診断の重視が成長を促進 74
6.3 画像診断デバイス 75
6.3.1 CT 76
6.3.2 超音波 77
- 6.3.2.1 超音波の低侵襲性が需要を押し上げる 77
6.3.3 X線 78
6.3.4 MRI 79
- 6.3.4.1 MRIアプリケーションの革新と進歩が需要を牽引 79
6.3.5 その他の画像診断機器 80
6.4 その他デバイス 81
7 診断薬受託製造の市場、サービス別 83
7.1 イントロダクション 84
7.2 デバイス開発・製造サービス 84
7.2.1 デバイス製造サービスは予測期間中に高成長を遂げる 84
7.3 品質管理サービス 85
7.4 包装・組立サービス 86
7.4.1 成長を支える医療機器の安全性への関心の高まり 86
7.5 その他サービス 87
8 診断薬受託製造の市場、用途別 88
8.1 イントロダクション 89
8.2 体外診断装置アプリケーション 89
8.2.1 感染症 89
8.2.2 糖尿病 90
8.2.3 オンコロジー 91
- 8.2.3.1 がんの早期発見への取り組みの高まりが成長の原動力に 91
8.2.4 循環器内科 92
8.2.5 その他のアプリケーション（ivdデバイス） 92
8.3 画像診断装置アプリケーション 93
8.3.1 循環器内科 94
- 8.3.1.1 CVD有病率の高さが成長を牽引 94
8.3.2 オンコロジー 94
8.3.3 整形外科 95
8.3.4 神経学 96
- 8.3.4.1 成長を牽引する3D MRI技術の革新 96
8.3.5 その他の用途（画像診断装置） 96
8.4 その他のデバイス・アプリケーション 97
8.4.1 消化器内科 98
- 8.4.1.1 早期診断への需要の高まりが成長を後押し 98
8.4.2 婦人科 99
- 8.4.2.1 女性のがん患者数の増加が成長の原動力に 99
8.4.3 その他のアプリケーション（その他のデバイス） 99
9 診断薬受託製造の市場、地域別 101
9.1 イントロダクション 102
9.2 アジア太平洋 102
9.2.1 アジア太平洋地域：景気後退の影響 102
9.2.2 中国 107
9.2.3 日本 110
- 9.2.3.1 高度な医療診断ツールへのニーズが成長の原動力に 110
9.2.4 インド 113
- 9.2.4.1 成長を支える製造受託能力の向上 113
9.2.5 その他のアジア太平洋 116
9.3 北米 119
9.3.1 北米：景気後退の影響 119
9.3.2 米国 124
- 9.3.2.1 社内製造コストの上昇により、受託製造へのシフトが進む 124
9.3.3 カナダ 127
- 9.3.3.1 市場を拡大する主要製造企業の存在感 127
9.4 ヨーロッパ 131
9.4.1 欧州：経済不況の影響 131
9.4.2 ドイツ 135
- 9.4.2.1 ドイツが欧州最大の市場シェアを占める 135
9.4.3 フランス 139
9.4.4 英国 142
- 9.4.4.1 体外診断用医薬品の入手しやすさが成長の原動力に 142
9.4.5 イタリア 145
- 9.4.5.1 成長を抑制するインフラの欠如 145
9.4.6 スペイン 148
9.4.7 その他のヨーロッパ 151
9.5 その他の地域 154
9.5.1 ラテンアメリカ：経済不況の影響 155
9.5.2 中東・アフリカ：景気後退の影響 155
10 競合情勢 159
10.1 概要 159
10.2 キープレーヤーの戦略／勝利への権利 159
10.2.1 診断薬受託製造の主要メーカーが採用する戦略の概要 159
10.3 収益分析 160
10.4 市場シェア分析 161
10.5 企業評価マトリックス 163
10.5.1 STARS 163
10.5.2 EMERGING LEADERS 163
10.5.3 PERVASIVE PLAYERS 163
10.5.4 PARTICIPANTS 163
10.6 企業のフットプリント分析 165
10.7 競合ベンチマーキング 168
10.8 競合シナリオ 169
10.8.1 製品/サービスの発表と承認 169
10.8.2 ディール 170
10.8.3 その他の展開 171
11 企業プロファイル 172
11.1 主要企業 172
11.1.1 JABIL INC 172
11.1.2 FLEX LTD 176
11.1.3 PLEXUS CORP 178
11.1.4 SANMINA CORPORATION 181
11.1.5 TE CONNECTIVITY LTD 185
11.1.6 CELESTICA INC 188
11.1.7 INTEGER HOLDINGS CORPORATION 190
11.1.8 NIPRO CORPORATION 192
11.1.9 THERMO FISHER SCIENTIFIC 195
11.1.10 WEST PHARMACEUTICAL SERVICES, INC 198
11.1.11 BENCHMARK ELECTRONICS INC 200
11.1.12 KIMBALL ELECTRONICS INC 203
11.1.13 KMC SYSTEMS 206
11.1.14 SAVYON DIAGNOSTICS 208
11.1.15 NOVA BIOMEDICAL 209
11.2 他の有力企業 211
11.2.1 CENOGENICS CORPORATION 211
11.2.2 CONE BIOPRODUCTS 211
11.2.3 AVIOQ, INC 212
11.2.4 PHILLIPS-MEDISIZE CORPORATION 213
11.2.5 INVETECH 214
11.2.6 MERIDIAN BIOSCIENCE, INC 214
11.2.7 NOLATO AB 216
11.2.8 FUJIREBIO 217
11.2.9 SEKISUI 218
11.2.10 PRESTIGE DIAGNOSTICS 218
11.2.11 BIOKIT 219
12 付録 220
12.1 ディスカッションガイド 220
12.2 ナレッジストア 224
12.3 カスタマイズオプション 226
12.4 関連レポート 226
12.5 執筆者の詳細 227
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
Table of Contents
1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.3 STUDY SCOPE 32
1.3.1 YEARS CONSIDERED 33
1.4 CURRENCY CONSIDERED 33
1.5 STAKEHOLDERS 33
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
2.1.1 SECONDARY DATA 35
- 2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 37
2.1.3 KEY INDUSTRY INSIGHTS 38
- 2.1.3.1 Key data from primary sources 38
- 2.1.3.2 Breakdown of primary interviews 39
2.2 MARKET SIZE ESTIMATION 39
2.2.1 BOTTOM-UP APPROACH 39
- 2.2.1.1 Approach 1: Company revenue estimation approach 40
- 2.2.1.2 Approach 2: Presentations of companies and primary interviews 40
- 2.2.1.3 Approach 3: COGS approach 40
- 2.2.1.4 Approach 4: Parent market approach (in-house vs. outsourcing market) 41
- 2.2.1.5 Growth forecast 42
- 2.2.1.6 CAGR projections 42
2.2.2 TOP-DOWN APPROACH 42
2.3 DATA TRIANGULATION 44
2.4 STUDY ASSUMPTIONS 45
2.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 45
3 EXECUTIVE SUMMARY 47
4 PREMIUM INSIGHTS 50
4.1 DIAGNOSTIC CONTRACT MANUFACTURING MARKET OVERVIEW 50
4.2 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION (2023-2028) 51
4.3 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE AND COUNTRY (2022) 52
4.4 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
5.2.1 DRIVERS 55
- 5.2.1.1 Increasing demand for early diagnosis and widening scope of clinical applications 55
- 5.2.1.2 Adoption of robotics and automation in manufacturing processes 55
- 5.2.1.3 Growing outsourcing activity by IVD manufacturers 56
- 5.2.1.4 High cost of in-house IVD manufacturing 56
5.2.2 RESTRAINTS 57
- 5.2.2.1 IP protection concerns and possibility of IP theft 57
5.2.3 OPPORTUNITIES 57
- 5.2.3.1 Growth opportunities in emerging economies 57
5.2.4 CHALLENGES 57
- 5.2.4.1 Increasing adoption of refurbished diagnostic imaging systems 57
- 5.2.4.2 Lack of constant innovation to balance technological capabilities against costs 58
- 5.2.4.3 Shortage of skilled labor 58
5.3 SUPPLY CHAIN ANALYSIS 58
5.4 PORTER’S FIVE FORCES ANALYSIS 59
5.4.1 THREAT OF NEW ENTRANTS 59
5.4.2 THREAT OF SUBSTITUTES 60
5.4.3 BARGAINING POWER OF SUPPLIERS 60
5.4.4 BARGAINING POWER OF BUYERS 60
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 61
5.5 ECOSYSTEM ANALYSIS 61
5.5.1 ROLE IN ECOSYSTEM 62
5.6 REGULATORY ANALYSIS 63
5.6.1 NORTH AMERICA 64
- 5.6.1.1 US 64
- 5.6.1.2 Canada 64
5.6.2 EUROPE 65
5.6.3 ASIA PACIFIC 65
- 5.6.3.1 Japan 65
- 5.6.3.2 China 66
- 5.6.3.3 India 68
5.7 KEY CONFERENCES AND EVENTS IN 2022-2023 68
5.8 TECHNOLOGY ANALYSIS 70
6 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE 71
6.1 INTRODUCTION 72
6.2 IN VITRO DIAGNOSTIC DEVICES 72
6.2.1 IVD CONSUMABLES 73
- 6.2.1.1 Consumables segment to dominate IVD contract manufacturing market 73
6.2.2 IVD EQUIPMENT 74
- 6.2.2.1 Automation, advancements, and emphasis on efficient diagnostics to drive growth 74
6.3 DIAGNOSTIC IMAGING DEVICES 75
6.3.1 CT 76
- 6.3.1.1 Rising adoption of CT scanners for detection of tumors to support growth 76
6.3.2 ULTRASOUND 77
- 6.3.2.1 Minimally invasive nature of ultrasound to boost demand 77
6.3.3 X-RAY 78
- 6.3.3.1 Low cost of X-ray imaging compared to other modalities to drive growth 78
6.3.4 MRI 79
- 6.3.4.1 Innovation and advancement in MRI applications to drive demand 79
6.3.5 OTHER DIAGNOSTIC IMAGING DEVICES 80
6.4 OTHER DEVICES 81
7 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE 83
7.1 INTRODUCTION 84
7.2 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES 84
7.2.1 DEVICE MANUFACTURING SERVICES TO WITNESS HIGH GROWTH DURING FORECAST PERIOD 84
7.3 QUALITY MANAGEMENT SERVICES 85
7.3.1 STRINGENT REGULATIONS AND INCREASING PRODUCT SAFETY CONCERNS TO DRIVE DEMAND FOR QUALITY MANAGEMENT SERVICES 85
7.4 PACKAGING AND ASSEMBLY SERVICES 86
7.4.1 INCREASING PRODUCT SAFETY CONCERNS FOR MEDICAL DEVICES TO SUPPORT GROWTH 86
7.5 OTHER SERVICES 87
8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY APPLICATION 88
8.1 INTRODUCTION 89
8.2 IN VITRO DIAGNOSTIC DEVICE APPLICATIONS 89
8.2.1 INFECTIOUS DISEASES 89
- 8.2.1.1 Increasing incidence of infectious diseases to drive adoption of IVD devices 89
8.2.2 DIABETES 90
- 8.2.2.1 Rising prevalence of diabetes to drive adoption of glucose monitoring devices 90
8.2.3 ONCOLOGY 91
- 8.2.3.1 Rising initiatives for early detection of cancer to drive growth 91
8.2.4 CARDIOLOGY 92
- 8.2.4.1 Increasing use of immunoassays in detection of CVD to drive growth 92
8.2.5 OTHER APPLICATIONS (IVD DEVICES) 92
8.3 DIAGNOSTIC IMAGING DEVICE APPLICATIONS 93
8.3.1 CARDIOLOGY 94
- 8.3.1.1 High prevalence of CVD to drive growth 94
8.3.2 ONCOLOGY 94
- 8.3.2.1 Wide adoption of nuclear imaging systems to distinguish between benign and malignant tumors to drive growth 94
8.3.3 ORTHOPEDICS 95
- 8.3.3.1 Effective diagnosis and prognosis of musculoskeletal disorders by imaging devices to drive growth 95
8.3.4 NEUROLOGY 96
- 8.3.4.1 Innovations in 3D MRI technology to drive growth 96
8.3.5 OTHER APPLICATIONS (DIAGNOSTIC IMAGING DEVICES) 96
8.4 OTHER DEVICE APPLICATIONS 97
8.4.1 GASTROENTEROLOGY 98
- 8.4.1.1 Surging demand for early diagnosis to propel growth 98
8.4.2 GYNECOLOGY 99
- 8.4.2.1 Rising cases of cancer among women to drive growth 99
8.4.3 OTHER APPLICATIONS (OTHER DEVICES) 99
9 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION 101
9.1 INTRODUCTION 102
9.2 ASIA PACIFIC 102
9.2.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION 102
9.2.2 CHINA 107
- 9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive growth 107
9.2.3 JAPAN 110
- 9.2.3.1 Need for advanced medical diagnostic tools to fuel growth 110
9.2.4 INDIA 113
- 9.2.4.1 Rising contract manufacturing capabilities to support growth 113
9.2.5 REST OF ASIA PACIFIC 116
9.3 NORTH AMERICA 119
9.3.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION 119
9.3.2 US 124
- 9.3.2.1 Rising in-house manufacturing costs to drive shift toward contract manufacturing 124
9.3.3 CANADA 127
- 9.3.3.1 Strong presence of key manufacturing companies to augment market 127
9.4 EUROPE 131
9.4.1 EUROPE: IMPACT OF ECONOMIC RECESSION 131
9.4.2 GERMANY 135
- 9.4.2.1 Germany to hold largest market share in Europe 135
9.4.3 FRANCE 139
- 9.4.3.1 Strong focus on research and innovation of diagnostic devices to drive growth 139
9.4.4 UK 142
- 9.4.4.1 Increasing accessibility of IVD devices to drive growth 142
9.4.5 ITALY 145
- 9.4.5.1 Lack of supporting infrastructure to restrain growth 145
9.4.6 SPAIN 148
- 9.4.6.1 Increasing demand for diagnostic equipment to boost demand for contract manufacturing 148
9.4.7 REST OF EUROPE 151
9.5 REST OF THE WORLD 154
9.5.1 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION 155
9.5.2 MIDDLE EAST & AFRICA: IMPACT OF ECONOMIC RECESSION 155
10 COMPETITIVE LANDSCAPE 159
10.1 OVERVIEW 159
10.2 STRATEGIES OF KEY PLAYERS/RIGHT TO WIN 159
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY DIAGNOSTIC CONTRACT MANUFACTURERS 159
10.3 REVENUE ANALYSIS 160
10.4 MARKET SHARE ANALYSIS 161
10.5 COMPANY EVALUATION MATRIX 163
10.5.1 STARS 163
10.5.2 EMERGING LEADERS 163
10.5.3 PERVASIVE PLAYERS 163
10.5.4 PARTICIPANTS 163
10.6 FOOTPRINT ANALYSIS OF COMPANIES 165
10.7 COMPETITIVE BENCHMARKING 168
10.8 COMPETITIVE SCENARIO 169
10.8.1 PRODUCT/SERVICE LAUNCHES AND APPROVALS 169
10.8.2 DEALS 170
10.8.3 OTHER DEVELOPMENTS 171
11 COMPANY PROFILES 172
11.1 KEY PLAYERS 172
11.1.1 JABIL INC 172
11.1.2 FLEX LTD 176
11.1.3 PLEXUS CORP 178
11.1.4 SANMINA CORPORATION 181
11.1.5 TE CONNECTIVITY LTD 185
11.1.6 CELESTICA INC 188
11.1.7 INTEGER HOLDINGS CORPORATION 190
11.1.8 NIPRO CORPORATION 192
11.1.9 THERMO FISHER SCIENTIFIC 195
11.1.10 WEST PHARMACEUTICAL SERVICES, INC 198
11.1.11 BENCHMARK ELECTRONICS INC 200
11.1.12 KIMBALL ELECTRONICS INC 203
11.1.13 KMC SYSTEMS 206
11.1.14 SAVYON DIAGNOSTICS 208
11.1.15 NOVA BIOMEDICAL 209
11.2 OTHER PLAYERS 211
11.2.1 CENOGENICS CORPORATION 211
11.2.2 CONE BIOPRODUCTS 211
11.2.3 AVIOQ, INC 212
11.2.4 PHILLIPS-MEDISIZE CORPORATION 213
11.2.5 INVETECH 214
11.2.6 MERIDIAN BIOSCIENCE, INC 214
11.2.7 NOLATO AB 216
11.2.8 FUJIREBIO 217
11.2.9 SEKISUI 218
11.2.10 PRESTIGE DIAGNOSTICS 218
11.2.11 BIOKIT 219
12 APPENDIX 220
12.1 DISCUSSION GUIDE 220
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 224
12.3 CUSTOMIZATION OPTIONS 226
12.4 RELATED REPORTS 226
12.5 AUTHOR DETAILS 227
TABLE 1 INCLUSIONS AND EXCLUSIONS TABLE 2 RISK ASSESSMENT: DIAGNOSTIC CONTRACT MANUFACTURING MARKET TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING DIAGNOSTIC CONTRACT MANUFACTURING TABLE 4 US: CLASSIFICATION OF MEDICAL EQUIPMENT TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA TABLE 6 JAPAN: CLASSIFICATION OF IVD REAGENTS TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES TABLE 8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2022-2023 TABLE 9 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 10 IN VITRO DIAGNOSTIC DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 11 IN VITRO DIAGNOSTIC DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 12 IVD CONSUMABLES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 13 IVD EQUIPMENT: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 14 DIAGNOSTIC IMAGING DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 15 DIAGNOSTIC IMAGING DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 16 CT: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 17 ULTRASOUND: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 18 X-RAY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 19 MRI: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 20 OTHER DIAGNOSTIC IMAGING DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 21 OTHER DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 22 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 23 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 24 QUALITY MANAGEMENT SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 25 PACKAGING AND ASSEMBLY SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 26 OTHER SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 27 IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 28 INFECTIOUS DISEASES: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 29 DIABETES: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 30 ONCOLOGY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 31 CARDIOLOGY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 32 OTHER APPLICATIONS: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 33 DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 34 CARDIOLOGY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 35 ONCOLOGY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 36 ORTHOPEDICS: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 37 NEUROLOGY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 38 OTHER APPLICATIONS: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 39 OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 40 ESTIMATED NEW GI CANCER CASES AND DEATHS IN US, 2021 TABLE 41 GASTROENTEROLOGY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 42 GYNECOLOGY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 43 OTHER APPLICATIONS: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 44 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 45 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 46 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 47 ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 48 ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 49 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 50 ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 51 ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 52 ASIA PACIFIC: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 53 CHINA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 54 CHINA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 55 CHINA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 56 CHINA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 57 CHINA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 58 CHINA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 59 CHINA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 60 JAPAN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 61 JAPAN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 62 JAPAN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 63 JAPAN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 64 JAPAN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 65 JAPAN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 66 JAPAN: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 67 INDIA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 68 INDIA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 69 INDIA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 70 INDIA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 71 INDIA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 72 INDIA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 73 INDIA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 74 REST OF ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 75 REST OF ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 76 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 77 REST OF ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 78 REST OF ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 79 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 80 REST OF ASIA PACIFIC: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 81 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 82 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 83 NORTH AMERICA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 84 NORTH AMERICA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 85 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 86 NORTH AMERICA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 87 NORTH AMERICA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 88 NORTH AMERICA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 89 US: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 90 US: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 91 US: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 92 US: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 93 US: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 94 US: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 95 US: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 96 CANADA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 97 CANADA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 98 CANADA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 99 CANADA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 100 CANADA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 101 CANADA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 102 CANADA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 103 EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 104 EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 105 EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 106 EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 107 EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 108 EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 109 EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 110 EUROPE: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 111 GERMANY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 112 GERMANY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 113 GERMANY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 114 GERMANY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 115 GERMANY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 116 GERMANY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 117 GERMANY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 118 FRANCE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 119 FRANCE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 120 FRANCE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 121 FRANCE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 122 FRANCE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 123 FRANCE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 124 FRANCE: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 125 UK: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 126 UK: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 127 UK: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 128 UK: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 129 UK: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 130 UK: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 131 UK: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 132 ITALY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 133 ITALY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 134 ITALY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 135 ITALY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 136 ITALY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 137 ITALY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 138 ITALY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 139 SPAIN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 140 SPAIN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 141 SPAIN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 142 SPAIN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 143 SPAIN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 144 SPAIN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 145 SPAIN: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 146 REST OF EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 147 REST OF EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 148 REST OF EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 149 REST OF EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 150 REST OF EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 151 REST OF EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 152 REST OF EUROPE: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 153 REST OF THE WORLD: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION) TABLE 154 REST OF THE WORLD: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 155 REST OF THE WORLD: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 156 REST OF THE WORLD: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION) TABLE 157 REST OF THE WORLD: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 158 REST OF THE WORLD: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 159 REST OF THE WORLD: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 160 OVERALL FOOTPRINT OF COMPANIES TABLE 161 DEVICE TYPE FOOTPRINT OF COMPANIES TABLE 162 REGIONAL FOOTPRINT OF COMPANIES TABLE 163 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: LIST OF KEY START-UP/SME PLAYERS TABLE 164 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: PRODUCT/SERVICE LAUNCHES AND APPROVALS, 2020-2023 TABLE 165 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: DEALS, 2020-2023 TABLE 166 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: OTHER DEVELOPMENTS, 2020-2023 TABLE 167 JABIL INC.: COMPANY OVERVIEW TABLE 168 FLEX LTD.: COMPANY OVERVIEW TABLE 169 PLEXUS CORP.: COMPANY OVERVIEW TABLE 170 SANMINA CORPORATION: COMPANY OVERVIEW TABLE 171 TE CONNECTIVITY LTD.: COMPANY OVERVIEW TABLE 172 CELESTICA INC.: COMPANY OVERVIEW TABLE 173 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW TABLE 174 NIPRO CORPORATION: COMPANY OVERVIEW TABLE 175 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW TABLE 176 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW TABLE 177 BENCHMARK ELECTRONICS INC.: COMPANY OVERVIEW TABLE 178 KIMBALL ELECTRONICS INC.: COMPANY OVERVIEW TABLE 179 KMC SYSTEMS: COMPANY OVERVIEW TABLE 180 SAVYON DIAGNOSTICS: COMPANY OVERVIEW TABLE 181 NOVA BIOMEDICAL: COMPANY OVERVIEW
FIGURE 1 DIAGNOSTIC CONTRACT MANUFACTURING MARKET SEGMENTATION FIGURE 2 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: RESEARCH DESIGN METHODOLOGY FIGURE 3 PRIMARY SOURCES FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH FIGURE 6 DEMAND-SIDE ESTIMATION FOR DIAGNOSTIC CONTRACT MANUFACTURING MARKET FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS FIGURE 8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: TOP-DOWN APPROACH FIGURE 9 DATA TRIANGULATION METHODOLOGY FIGURE 10 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2023 VS. 2028 (USD MILLION) FIGURE 11 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2023 VS. 2028 (USD MILLION) FIGURE 12 IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) FIGURE 13 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2023 VS. 2028 (USD MILLION) FIGURE 14 HIGH COST OF IN-HOUSE MANUFACTURING TO DRIVE DEMAND FOR DIAGNOSTIC CONTRACT MANUFACTURING FIGURE 15 ASIA PACIFIC MARKET TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD FIGURE 16 IVD DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET IN 2022 FIGURE 17 MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD FIGURE 18 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FIGURE 19 DIAGNOSTIC CONTRACT MANUFACTURING: SUPPLY CHAIN FIGURE 20 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: ECOSYSTEM ANALYSIS FIGURE 21 KEY PLAYERS IN DIAGNOSTIC CONTRACT MANUFACTURING MARKET ECOSYSTEM FIGURE 22 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET SNAPSHOT FIGURE 23 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET SNAPSHOT FIGURE 24 REVENUE ANALYSIS OF KEY PLAYERS FIGURE 25 IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET: DEGREE OF COMPETITION FIGURE 26 DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET: DEGREE OF COMPETITION FIGURE 27 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (2022) FIGURE 28 JABIL INC.: COMPANY SNAPSHOT (2022) FIGURE 29 FLEX LTD.: COMPANY SNAPSHOT (2022) FIGURE 30 PLEXUS CORP.: COMPANY SNAPSHOT (2022) FIGURE 31 SANMINA CORPORATION: COMPANY SNAPSHOT (2022) FIGURE 32 TE CONNECTIVITY LTD.: COMPANY SNAPSHOT (2022) FIGURE 33 CELESTICA INC.: COMPANY SNAPSHOT (2022) FIGURE 34 INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022) FIGURE 35 NIPRO CORPORATION: COMPANY SNAPSHOT (2022) FIGURE 36 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022) FIGURE 37 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2022) FIGURE 38 BENCHMARK ELECTRONICS INC.: COMPANY SNAPSHOT (2022) FIGURE 39 KIMBALL ELECTRONICS INC.: COMPANY SNAPSHOT (2022)
